Suppr超能文献

肠球菌中基因型的新出现耐药性:治疗失败的潜在威胁。

Emerging resistance of genotype in enterococci: A potential menace for therapeutic failure.

作者信息

Ejaz Hasan

机构信息

Dr. Hasan Ejaz, PhD, Department of Clinical Laboratory Sciences, CAMS, Jouf University, Sakaka, Saudi Arabia.

出版信息

Pak J Med Sci. 2019 Nov-Dec;35(6):1659-1663. doi: 10.12669/pjms.35.6.1145.

Abstract

OBJECTIVES

Emerging cases of vancomycin-resistant enterococci (VRE) are detrimental for the patients. The current study aimed to ascertain the occurrence of VRE, their antibiogram and the genotype responsible for vancomycin resistance.

METHODS

A total number of 2,958 clinical specimens were processed at Microbiology Department of the Alrazi Health Care, Lahore during the one year (2016-2017) using microbiological culture media, biochemical and serology. Antibiogram of enterococcal strains was performed using disc diffusion and E-test. ATCC 29212 was used as a quality control strain. The detection of genotypes was accomplished by multiplex PCR assay.

RESULTS

Out of the 147 enterococci, 139 (94.6%) were , and 8 (5.4%) were . Statistically significant associations of urine (p < 0.001), pus (p < 0.001) and wound swabs (p = 0.001) were observed with . A significant correlation of enterococcal infections (p = 0.05) was seen with female patients. Four (2.9%) strains of found to be VRE with (75%) and (25%) genotypes.

CONCLUSION

The emerging strains of VRE ( and genotype) in the current study are a potential menace for therapeutic failure, which left the physicians with only linezolid as a therapeutic option.

摘要

目的

耐万古霉素肠球菌(VRE)新出现的病例对患者有害。本研究旨在确定VRE的发生率、它们的抗菌谱以及导致万古霉素耐药的基因型。

方法

在一年时间(2016 - 2017年)里,拉合尔的阿尔拉齐医疗保健中心微生物科使用微生物培养基、生化和血清学方法对总共2958份临床标本进行了处理。使用纸片扩散法和E试验对肠球菌菌株进行抗菌谱检测。将ATCC 29212用作质量控制菌株。通过多重PCR检测法完成基因型的检测。

结果

在147株肠球菌中,139株(94.6%)为[此处原文缺失相关内容],8株(5.4%)为[此处原文缺失相关内容]。观察到尿液(p < 0.001)、脓液(p < 0.001)和伤口拭子(p = 0.001)与[此处原文缺失相关内容]有统计学上的显著关联。女性患者的肠球菌感染有显著相关性(p = 0.05)。发现4株(2.9%)[此处原文缺失相关内容]菌株为VRE,其基因型为[此处原文缺失相关内容](75%)和[此处原文缺失相关内容](25%)。

结论

本研究中VRE的新出现菌株([此处原文缺失相关内容]和[此处原文缺失相关内容]基因型)是治疗失败的潜在威胁,这使得医生只剩下利奈唑胺作为治疗选择。

相似文献

1
Emerging resistance of genotype in enterococci: A potential menace for therapeutic failure.
Pak J Med Sci. 2019 Nov-Dec;35(6):1659-1663. doi: 10.12669/pjms.35.6.1145.
4
Gastrointestinal Colonization with Vancomycin-Resistant Enterococci In Hospitalized and Outpatients.
Open Access Maced J Med Sci. 2015 Mar 15;3(1):7-11. doi: 10.3889/oamjms.2015.002. Epub 2014 Nov 5.
6
Antibiogram of Urinary Isolates from a Tertiary Care Hospital.
Infect Disord Drug Targets. 2021;21(1):146-150. doi: 10.2174/1871526520666200403140618.
7
Genotypic Characterization of Vancomycin-Resistant Enterococcus spp. In Tertiary Center, Iran.
Infect Disord Drug Targets. 2017;17(2):90-94. doi: 10.2174/1871526517666170210164649.
9
Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci.
J Clin Microbiol. 1997 Mar;35(3):703-7. doi: 10.1128/jcm.35.3.703-707.1997.
10
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates.
J Clin Microbiol. 1998 Aug;36(8):2187-90. doi: 10.1128/JCM.36.8.2187-2190.1998.

本文引用的文献

6
Phenotypic characterization of ESBL producing Enterobacter cloacae among children.
Pak J Med Sci. 2013 Jan;29(1):144-7. doi: 10.12669/pjms.291.2385.
7
Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs.
Antimicrob Resist Infect Control. 2013 Nov 4;2(1):30. doi: 10.1186/2047-2994-2-30.
10
Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients.
Mem Inst Oswaldo Cruz. 2012 Feb;107(1):57-63. doi: 10.1590/s0074-02762012000100008.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验